UBS O'Connor’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-34,626
Closed -$1.69M – 718
2022
Q4
$1.69M Buy
+34,626
New +$1.6M 0.03% 499
2018
Q2
– Sell
-50,000
Closed -$1.21M – 358
2018
Q1
$1.21M Hold
50,000
– – 0.02% 217
2017
Q4
$758K Hold
50,000
– – 0.01% 254
2017
Q3
$822K Sell
50,000
-357,889
-88% -$6.07M 0.01% 294
2017
Q2
$7.89M Buy
407,889
+157,889
+63% +$2.75M 0.13% 143
2017
Q1
$4.43M Buy
+250,000
New +$4.64M 0.07% 225

Other funds holding THC

UBS O'Connor's THC Position: Q1 2023 in Review

UBS O'Connor sold out of Tenet Healthcare (THC) in Q1 2023, closing a stake of 34,626 shares — an estimated $1.69M sold.

UBS O'Connor first reported a position in THC in Q1 2017 and held it in 6 quarters. The position peaked at $7.89M in Q2 2017. 365 funds tracked by Wall St. Rank hold THC as of Q1 2023.

  • UBS O'Connor reported no remaining Tenet Healthcare position as of Q1 2023 after selling out during the quarter.
  • UBS O'Connor sold 34,626 Tenet Healthcare shares in Q1 2023, an estimated $1.69M.
  • UBS O'Connor first reported a position in Tenet Healthcare in Q1 2017 and held it in 6 quarters.
  • UBS O'Connor's Tenet Healthcare position peaked at $7.89M in Q2 2017.
  • 365 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2023.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.